ELAINE ZOBRIST: Open Payments
NPI 1104368018 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,951 in 162 payments from 16 companies in 2025. Trend: 2023 $8,772 · 2024 $10,010 · 2025 $14,951
Speaker / faculty: $10,125Food & beverage: $4,045Travel & lodging: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $12,349 |
| UCB, Inc. | 23 | $660 |
| Amgen Inc. | 19 | $300 |
| Novartis Pharmaceuticals Corporation | 9 | $250 |
| AstraZeneca Pharmaceuticals LP | 10 | $236 |
| Lilly USA, LLC | 8 | $225 |
| GlaxoSmithKline, LLC. | 9 | $172 |
| PFIZER INC. | 9 | $148 |
| Janssen Biotech, Inc. | 5 | $140 |
| Mallinckrodt Hospital Products Inc. | 1 | $132 |
Products named: RINVOQ, Bimzelx, SAPHNELO, BENLYSTA, XELJANZ, TREMFYA, COSENTYX, ACTHAR.
Industry payments across MO — which companies pay providers there.
